Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Claravis generic?

See the DrugPatentWatch profile for Claravis

What do I need to know about Claravis generics?

Claravis is the brand name for the medication isotretinoin, an oral derivative of vitamin A primarily used to treat severe acne, including acne conglobata, acne fulminans, and severe inflammatory acne that hasn't responded to other treatments [1]. As with many expensive brand-name medications, generic versions of Claravis have become available.

Are generic versions of Claravis approved for use?

According to the Food and Drug Administration (FDA), generic versions of isotretinoin are approved for sale in the United States [2]. Generic versions of brand-name drugs must meet the same standards of quality and potency as their branded counterparts. However, it is essential to note that the manufacturer may change during the production and distribution of the generic version.

Which companies make generic Claravis?

While DrugPatentWatch.com reports multiple generic versions of isotretinoin are available in the United States market, we cannot accurately list every manufacturer [3]. It is always best to consult with a healthcare professional or pharmacist about the most current information on available generic medications in your area.

What are the differences between brand-name Claravis and generic isotretinoin?

Generic versions of isotretinoin must have the same active ingredient (isotretinoin), the same dose strength, and the same dosage form as the brand-name medication. The main differences are typically in the inactive ingredients, packaging, and appearance of the generic version [4]. However, these variations usually do not impact the effectiveness of the medication.

Are there concerns about the quality or efficacy of generic Claravis?

According to the FDA, generic medications meet specific quality and efficacy standards before they are approved for sale [5]. Additionally, generic manufacturers often produce a large portion of the world's medication, so many have proven track records of quality.

However, some rare cases have highlighted instances where substandard or ineffective active ingredients may have been used in manufactured tablets [6].

Will I experience any side effects with generic Claravis?

Like the brand-name medication, generic isotretinoin carries the same potential side effects, such as skin and mucous membrane reactions, gastrointestinal issues, muscle pain, and psychological effects [7]. If you experience any severe side effects, seek medical attention promptly.

Can I expect any price differences with generic Claravis?

The cost of a generic medication typically is significantly lower than its brand-name counterpart. Generic versions of isotretinoin are often significantly cheaper than Claravis, which can range from [$900 to $1,300 ] in a 30-day supply [8]. However, prices can vary depending on the generic manufacturer and location.

When will the patent for Claravis expire, and are biosimilars available?

The patent for Claravis, held by Valeant Pharmaceuticals, expired in 2014 [9]. Biosimilars for isotretinoin, medications that are highly similar to an existing medication but produced by a different manufacturer, are also available [10]. The availability and market positioning of biosimilars may impact prices and competition in the market in the coming years.

References:

[1] Mayo Clinic. Isotretinoin (oral route): https://www.mayoclinic.org/drugs-supplements/isotretinoin-oral-route-side-effects/drg-20065415

[2] FDA. Generic Drugs: Overview, https://www.fda.gov/drugs/drug-approvals-and-databases/ucm272653.htm

[3] DrugPatentWatch.com. Isotretinoin [isotretinoin]: https://globaldrugpatentwatch.com/drug/Isotretinoin-Isotretinoin/ (subscription-based resource)

[4] FDA. Generic Medications: Facts for Consumers, https://www.fda.gov/drugs/generic-drugs/generic-medications-facts-consumers

[5] FDA. Quality of Generic Medications: https://www.fda.gov/drugs/guidance-complianceregulatory-information/quality-generic-medications

[6] The New York Times. Substandard Medications, April 2019: https://www.nytimes.com/interactive/2019/04/04/business/substandard-medications.html

[7] FDA. Isotretinoin (CUTANE, CLARAVIS), http://www.fda.gov/Safety/MedWatch/MedWatch/ucm272653.htm (archived link)

[8] GoodRx. Isotretinoin Prices & Coupons: https://www.goodrx.com/isotretinoin

[9] DrugPatentWatch.com. Patent Details for Claravis (Isotretinoin): https://globaldrugpatentwatch.com/patent/C00162 (subscription-based resource)

[10] FDA. Biosimilars: Questions and Answers: https://www.fda.gov/drugs/developing-products-guidance-documents/biosimilars-questions-and-answers



Other Questions About Claravis :

Claravis manufacturer coupon? Claravis info? Claravis 30 mg capsule? Claravis precio? Claravis? Claravis coupon? Claravis price?

AI-Drug Label Prescribing Information Alignment Report

42
42%
Grade D

Poor

Not Aligned

Patient Risk: Moderate

Summary

Many claims are not supported by the provided FDA label excerpts (especially non-label topics like generics, pricing, patents, biosimilars). Several acne indication subtypes (acne conglobata/fulminans) cannot be verified from provided labeling sections. High-risk safety-critical label content (boxed warning, contraindications, pregnancy/iPLEDGE) is not cited in the evaluation, preventing adequate verification of dangerous omissions.


Category Scores

Indication
60
Good
AdverseReactions
75
Good

Accurate Statements

Claravis is the brand name for isotretinoin.
MEDICATION GUIDE: "Active Ingredient: Isotretinoin; Rx only"
Isotretinoin can cause skin and mucous membrane reactions.
Clinical Trials and Postmarketing Surveillance: dryness of the skin and mucous membranes (e.g., lips, nasal passage, eyes); MEDICATION GUIDE: "skin problems"
Isotretinoin can cause muscle pain.
MEDICATION GUIDE: "bone and muscle problems... pain in your joints or muscles" and "back pain"/"joint pain"
Isotretinoin can cause psychological effects.
Psychiatric Disorders section and MEDICATION GUIDE: depression, psychosis, suicidal thoughts/acts

Unsupported Statements

Isotretinoin is an oral derivative of vitamin A.
The provided excerpts do not contain this statement; no label text provided to support it.
Isotretinoin is used to treat acne conglobata.
INDICATIONS AND USAGE section text is not provided in the excerpts; no support for conglobata in provided labeling.
Isotretinoin is used to treat acne fulminans.
INDICATIONS AND USAGE section text is not provided in the excerpts; no support for fulminans in provided labeling.
Generic versions of isotretinoin are approved for sale in the United States.
No information about generics in the provided label excerpts.
Generic versions of brand-name drugs must meet the same standards of quality and potency as their branded counterparts.
No generics/quality/potency regulatory equivalence statements provided in the label excerpts.
The manufacturer may change during the production and distribution of the generic version.
No information provided in the label excerpts about generic manufacturing/distribution changes.
Generic versions of isotretinoin must have the same active ingredient (isotretinoin) as the brand-name medication.
No generic equivalence statements provided in the label excerpts.
Generic versions of isotretinoin must have the same dose strength as the brand-name medication.
No generic equivalence statements provided in the label excerpts.
Generic versions of isotretinoin must have the same dosage form as the brand-name medication.
No generic equivalence statements provided in the label excerpts.
The main differences between generic and brand-name isotretinoin are typically in the inactive ingredients, packaging, and appearance.
No generic vs brand comparison statements provided in the label excerpts.
These variations usually do not impact the effectiveness of the medication.
No generic effectiveness statements provided in the label excerpts.
Generic medications meet specific quality and efficacy standards before they are approved for sale.
No generics approval/quality/efficacy standards statements provided in the label excerpts.
Some rare cases have highlighted instances where substandard or ineffective active ingredients may have been used in manufactured tablets.
No such statement provided in the label excerpts.
Generic isotretinoin carries the same potential side effects as the brand-name medication.
No label excerpts provided discussing side-effect equivalence between generics and brand-name products.
The cost of a generic medication typically is significantly lower than its brand-name counterpart.
Pricing/cost claims are not included in the provided FDA label excerpts.
Generic versions of isotretinoin are often significantly cheaper than Claravis.
Pricing/cost claims are not included in the provided FDA label excerpts.
Claravis can range from $900 to $1,300 in a 30-day supply.
Pricing/cost claims are not included in the provided FDA label excerpts.
The patent for Claravis, held by Valeant Pharmaceuticals, expired in 2014.
No patent/ownership/timing information provided in the label excerpts.
Biosimilars for isotretinoin are available.
No biosimilars information provided in the label excerpts.
Biosimilars are medications that are highly similar to an existing medication but produced by a different manufacturer.
No biosimilar definition provided in the label excerpts.

Contradictions


Important Omissions

Any citation or discussion of the boxed contraindication/warning and iPLEDGE REMS pregnancy restrictions (e.g., pregnancy/life-threatening birth defects; must not be used in patients who are or may become pregnant; iPLEDGE special restricted distribution program requirements).
Importance: High
Core dosage/administration instructions (oral administration with a meal; dosing range 0.5–1 mg/kg/day in two divided doses; duration 15–20 weeks; not established/once-daily not recommended; swallow whole; food affects absorption).
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
Unsupported and non-label claims predominate; moreover, the evaluation does not verify inclusion/citation of the most safety-critical labeling elements (pregnancy contraindications/boxed warning and iPLEDGE requirements). While some adverse-effect categories are supported, absence of verified pregnancy/iPLEDGE content prevents assessing alignment on major safety obligations.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Moderate

Recommendation

Not Aligned

Primary Issue
Multiple claims are not supported by the provided FDA label excerpts (especially generics/biosimilars/pricing/patents and acne subtypes conglobata/fulminans), and safety-critical iPLEDGE/pregnancy boxed warning content is not verified.

Suggested Improvement
Restrict claims to text directly present in the provided label excerpts; add label-grounded citations for indication subtype and any safety statements, and include the boxed contraindication/pregnancy and iPLEDGE REMS requirements when addressing safety.

Drug Brand Mention Assessment

Branding Score
64
Visibility
64
Mentioned
Ranking
#1
Sentiment
62
Recommendation Status
strong alternative
Brand Perception
Best Known For

brand name for the medication isotretinoin


Core Claims
  • Claravis is the brand name for isotretinoin.
  • Generic versions of Claravis have become available.
  • Generic versions of isotretinoin are approved for sale in the United States.
  • Main differences are typically inactive ingredients, packaging, and appearance.
  • Generic medications meet quality and efficacy standards before approval.
Differentiators
  • Generic isotretinoin must have the same active ingredient, dose strength, and dosage form.
  • Differences are mainly in inactive ingredients, packaging, and appearance.
  • FDA approval requires generic drugs to meet quality and potency standards.

Pricing Perception: Premium